August 22, 2024
Genetic Signatures (ASX:GSS) – Changes to Genetic Signatures’ Board of Directors
June 7, 2024
Genetic Signatures (ASX:GSS) – Completion of Institutional Entitlement Offer and Placement
June 4, 2024
Genetic Signatures (ASX:GSS) – Allison Rossiter appointed as CEO
Genetic Signatures welcomes Allison Rossiter, as the incoming CEO.
May 31, 2024
Genetic Signatures (ASX:GSS) – Trading Halt 31st May 2024
Commencement of normal trading on Thursday, 6 June 2024.
